Table 1.

Baseline characteristics of treated patients

CharacteristicsParts A and A-1, n = 17Part A-2, n = 13All patients, N = 30
Age, years, median (range)67.0 (35–87)66.0 (33–82)66.5 (33–87)
Sex, n (%)
 Male10 (59)13 (100)23 (77)
 Female7 (41)0 (0)7 (23)
ECOG performance status, n (%)
 05 (29)5 (38)10 (33)
 112 (71)8 (62)20 (67)
Tumor type, n (%)
 Adenocarcinoma2 (12)0 (0)2 (7)
 Carcinoid/neuroendocrine2 (12)1 (8)3 (10)
 Colorectal3 (18)0 (0)3 (10)
 Melanoma2 (12)5 (38)7 (23)
 Merkel cell carcinoma0 (0)1 (8)1 (3)
 Non–small cell lung cancer5 (29)1 (8)6 (20)
 Prostate1 (6)2 (15)3 (10)
 Kaposi sarcoma1 (6)0 (0)1 (3)
 Soft tissue sarcoma1 (6)0 (0)1 (3)
 Peripheral nerve sheath tumor0 (0)1 (8)1 (3)
 Pancreatic adenocarcinoma0 (0)1 (8)1 (3)
 Squamous cell lung cancer0 (0)1 (8)1 (3)
Prior therapies, n (%)
 00 (0)5 (38)5 (17)
 12 (12)3 (23)5 (17)
 22 (12)3 (23)5 (17)
 ≥313 (76)2 (15)15 (50)

Abbreviation: ECOG, Eastern Cooperative Oncology Group.